Zdrowie i gospodarka · 02/03/2022
FDA Releases Guidance on Master Protocols for Oncology Drug Development
The FDA has published a final guidance for industry on master protocols, which enable the simultaneous evaluation of multiple drugs and cancer types in a single clinical trial, accelerating the development of oncology drugs and biologics.
Source: Federal Register — Food and Drug AdministrationOpen original release →